Today was a public hearing with the Food And Drug Administration to determine what diseases (a limit of 20) should be included in Patient-Focused Drug Development program. MIF was the only organization there represented by Jamie Troil (http://www.melanomamom.com/) with an excellent public testimoney. We next will submit our written document and urge the FDA to proceed with speed in approving melanoma therapies. Thank you Jamie for being our advocate!!